End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.
Zhang R, Saredy J, Shao Y, Yao T, Liu L, Saaoud F, Yang WY, Sun Y, Johnson C, Drummer C 4th, Fu H, Lu Y, Xu K, Liu M, Wang J, Cutler E, Yu D, Jiang X, Li Y, Li R, Wang L, Choi ET, Wang H, Yang X.
Zhang R, et al. Among authors: wang h, wang l, wang j.
Redox Biol. 2020 Jul;34:101460. doi: 10.1016/j.redox.2020.101460. Epub 2020 Feb 20.
Redox Biol. 2020.
PMID: 32179051
Free PMC article.